Optimizing Outcomes in Generalized Pustular Psoriasis With IL-36 Antagonists

Practical strategies to optimize diagnosis of generalized pustular psoriasis, looking at the latest clinical evidence evaluating targeted treatments.


160201461 1 Ai Cme Live Pc V5 Page 1

While there are no treatments specific to generalized pustular psoriasis, knowledge about disease pathogenesis is evolving, with IL-36 emerging a major drivers of disease. Join us as we discuss the latest evidence evaluating targeted treatments for challenging disease. 

To register go to
https://www.answersincme.com/TargetIL36GPP